-
Mashup Score: 0Up and down the ladder: The latest comings and goings - 15 hour(s) ago
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Pharmalittle: We're reading about Cigna biosimilar plans, a Vertex deal in South Africa, and more - 19 hour(s) ago
Cigna plans to make copies of AbbVie’s Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Vertex offers limited access to a cystic fibrosis drug in South Africa — and may undercut a court case - 20 hour(s) ago
“This is not a solution for all South African patients” and is “likely to widen the disparity between rich and poor,” advocates complained.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 5Colombia issues a compulsory license for an HIV medicine and 'plants a flag for global health equity' - 2 day(s) ago
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2Pharmalittle: We're reading about a Senate probe into Novo pricing, a new UTI antibiotic, and more - 2 day(s) ago
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 5Colombia issues a compulsory license for an HIV medicine and 'plants a flag for global health equity' - 2 day(s) ago
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 5Biosimilars haven't always yielded lower out-of-pocket costs for patients, study finds - 2 day(s) ago
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 5Colombia issues a compulsory license for an HIV medicine and 'plants a flag for global health equity' - 2 day(s) ago
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they’re set to cost the U.S. health care system and the federal government still more.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Pharmalittle: We're reading about Lilly buying a plant, a Pfizer antibiotic, and more - 4 day(s) ago
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
Up and Down the Ladder: Job Changes.. the latest comings & goings.. recognize anyone? https://t.co/e0jGgnns36 #pharma #biotech #jobs $ABBV $CVAC $BLCO $CMOPF